Cargando…
Endocine™, N3OA and N3OASq; Three Mucosal Adjuvants That Enhance the Immune Response to Nasal Influenza Vaccination
Annual outbreaks of seasonal influenza are controlled or prevented through vaccination in many countries. The seasonal vaccines used are either inactivated, currently administered parenterally, or live-attenuated given intranasally. In this study three mucosal adjuvants were examined for the influen...
Autores principales: | Falkeborn, Tina, Bråve, Andreas, Larsson, Marie, Åkerlind, Britt, Schröder, Ulf, Hinkula, Jorma |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3738562/ https://www.ncbi.nlm.nih.gov/pubmed/23950951 http://dx.doi.org/10.1371/journal.pone.0070527 |
Ejemplares similares
-
The intranasal adjuvant Endocine™ enhances both systemic and mucosal immune responses in aged mice immunized with influenza antigen
por: Falkeborn, Tina, et al.
Publicado: (2017) -
Long-Lasting Mucosal and Systemic Immunity against Influenza A Virus Is Significantly Prolonged and Protective by Nasal Whole Influenza Immunization with Mucosal Adjuvant N3 and DNA-Plasmid Expressing Flagellin in Aging In- and Outbred Mice
por: Hinkula, Jorma, et al.
Publicado: (2019) -
RNA is an Adjuvanticity Mediator for the Lipid-Based Mucosal Adjuvant, Endocine
por: Hayashi, Masayuki, et al.
Publicado: (2016) -
DNA-Encoded Flagellin Activates Toll-Like Receptor 5 (TLR5), Nod-like Receptor Family CARD Domain-Containing Protein 4 (NRLC4), and Acts as an Epidermal, Systemic, and Mucosal-Adjuvant
por: Nyström, Sanna, et al.
Publicado: (2013) -
Real-time PCR detection of Human Herpesvirus 1-5 in patients lacking clinical signs of a viral CNS infection
por: Sundén, Birgitta, et al.
Publicado: (2011)